Medication Discrepancies Identified by Medication Reconciliation Among Patients with Acute Coronary Syndrome

Overview

Journal Naunyn Schmiedebergs Arch Pharmacol

Specialty Pharmacology

Date 2024 May 2

PMID 38695910

Authors

Sara Ataei

Behrouz Makki

Erfan Ayubi

Shahaboddin Emami

Affiliations

Soon will be listed here.

Abstract

Medication errors such as medication discrepancies are known as one of the leading cause of death. Medication discrepancies mostly occur during admission and at time transfer of care and discharge. Medication reconciliation process has pivotal role to avert medication discrepancies and improve patient safety and quality. Patients with acute coronary syndrome (ACS) are prone to medication discrepancies due to acute manifestations, simultaneous use of different medicines and having different co-morbidities. This study aimed to determine medication discrepancies identified by medication reconciliation among patients with ACS. In an observational study, patients with ACS admitted to a specialized Hospital in Baneh County, Kurdistan province during September 2023 and January 2024 were included. Medication reconciliation process was done when the patient was admitted. The history of medicine use was collected through interviews with the patient, their caregivers, as well as observing the medicines that were accompany with the patients. Number and type of unintentional medication discrepancies and related factors were evaluated. A total of 280 ACS patients (mean age: 63.8 ± 14.2, male gender: 59.3%) were included in the study. About 68% had at least 2 underlying diseases. The mean daily medicines taken by the patients during admission were 8.5 ± 1.54. The number (percentage) of unintentional inconsistency was observed in 78 (27.3%), and omission (39.7%) and changes in dosage (20.5%) had the highest frequency of unintentional medication discrepancies, respectively. Cardiovascular agents such as anti-dyslipidemia and antiplatelet had the highest frequency of unintentional medication discrepancies. The number of underlying diseases and daily medications before hospitalization increase the odds of discrepancies by 2.15 and 1.49 times, respectively (p-value < 0.05). Medication discrepancies identified by medication reconciliation among patients is relatively common. Unintentional medication discrepancies that have the potential to harm the ACS patients should be given more attention, especially in patients with multiple comorbidities and polypharmacy.

Citing Articles

Medication Reconciliation of Patients by Pharmacist at the Time of Admission and Discharge from Adult Nephrology Wards.

Ahmadi H, Houshmand Y, Raees-Jalali G, Karimzadeh I Pharmacy (Basel). 2024; 12(6).

PMID: 39585096 PMC: 11587488. DOI: 10.3390/pharmacy12060170.

References

Al-Hashar A, Al-Zakwani I, Eriksson T, Al Zaabi M . Whose responsibility is medication reconciliation: Physicians, pharmacists or nurses? A survey in an academic tertiary care hospital. Saudi Pharm J. 2017; 25(1):52-58. PMC: 5310138. DOI: 10.1016/j.jsps.2015.06.012. View

Al-Rashoud I, Al-Ammari M, Al-Jadhey H, Alkatheri A, Poff G, Aldebasi T . Medication discrepancies identified during medication reconciliation among medical patients at a tertiary care hospital. Saudi Pharm J. 2017; 25(7):1082-1085. PMC: 5681327. DOI: 10.1016/j.jsps.2017.05.004. View

Alanazi A, Awwad S, Khan T, Asdaq S, Mohzari Y, Alanazi F . Medication reconciliation on discharge in a tertiary care Riyadh Hospital: An observational study. PLoS One. 2022; 17(3):e0265042. PMC: 8923456. DOI: 10.1371/journal.pone.0265042. View

Ali M, Lobos C, Abdelmegid M, El-Sayed A . The frequency and nature of medication errors in hospitalized patients with acute coronary syndrome. Int J Clin Pharm. 2017; 39(3):542-550. DOI: 10.1007/s11096-017-0457-z. View

Almanasreh E, Moles R, Chen T . The medication reconciliation process and classification of discrepancies: a systematic review. Br J Clin Pharmacol. 2016; 82(3):645-58. PMC: 5338112. DOI: 10.1111/bcp.13017. View

Parejo M, Juanes Borrego A, Altimiras Ruiz J, Crespi Monjo M, Garcia-Pelaez M, Calderon Hernanz B . Medication list assessment in Spanish hospital emergency departments. J Emerg Med. 2014; 48(4):416-23. DOI: 10.1016/j.jemermed.2014.06.063. View

Belda-Rustarazo S, Cantero-Hinojosa J, Salmeron-Garcia A, Gonzalez-Garcia L, Cabeza-Barrera J, Galvez J . Medication reconciliation at admission and discharge: an analysis of prevalence and associated risk factors. Int J Clin Pract. 2015; 69(11):1268-74. DOI: 10.1111/ijcp.12701. View

Bos J, Van den Bemt P, Kievit W, Pot J, Nagtegaal J, Wieringa A . A multifaceted intervention to reduce drug-related complications in surgical patients. Br J Clin Pharmacol. 2016; 83(3):664-677. PMC: 5306487. DOI: 10.1111/bcp.13141. View

Hammour K, Farha R, Yaacoub R, Salman Z, Basheti I . Impact of Pharmacist-Directed Medication Reconciliation in Reducing Medication Discrepancies: A Randomized Controlled Trial. Can J Hosp Pharm. 2022; 75(3):169-177. PMC: 9245405. DOI: 10.4212/cjhp.3143. View

10.

Kripalani S, Roumie C, Dalal A, Cawthon C, Businger A, Eden S . Effect of a pharmacist intervention on clinically important medication errors after hospital discharge: a randomized trial. Ann Intern Med. 2012; 157(1):1-10. PMC: 3575734. DOI: 10.7326/0003-4819-157-1-201207030-00003. View

11.

Kwan J, Lo L, Sampson M, Shojania K . Medication reconciliation during transitions of care as a patient safety strategy: a systematic review. Ann Intern Med. 2013; 158(5 Pt 2):397-403. DOI: 10.7326/0003-4819-158-5-201303051-00006. View

12.

Lahue B, Pyenson B, Iwasaki K, Blumen H, Forray S, Rothschild J . National burden of preventable adverse drug events associated with inpatient injectable medications: healthcare and medical professional liability costs. Am Health Drug Benefits. 2014; 5(7):1-10. PMC: 4031698. View

13.

Leguelinel-Blache G, Arnaud F, Bouvet S, Dubois F, Castelli C, Roux-Marson C . Impact of admission medication reconciliation performed by clinical pharmacists on medication safety. Eur J Intern Med. 2014; 25(9):808-14. DOI: 10.1016/j.ejim.2014.09.012. View

14.

Marinovic I, Marusic S, Mucalo I, Mesaric J, Vrca V . Clinical pharmacist-led program on medication reconciliation implementation at hospital admission: experience of a single university hospital in Croatia. Croat Med J. 2017; 57(6):572-581. PMC: 5209936. DOI: 10.3325/cmj.2016.57.572. View

15.

Moges T, Akalu T, Sema F . Unintended medication discrepancies and associated factors upon patient admission to the internal medicine wards: identified through medication reconciliation. BMC Health Serv Res. 2022; 22(1):1251. PMC: 9571466. DOI: 10.1186/s12913-022-08628-5. View

16.

Overbaugh K . Acute coronary syndrome. Am J Nurs. 2009; 109(5):42-52. DOI: 10.1097/01.NAJ.0000351508.39509.e2. View

17.

Psaty B, Koepsell T, Wagner E, LoGerfo J, Inui T . The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers. JAMA. 1990; 263(12):1653-7. View

18.

Rodriguez Vargas B, Delgado Silveira E, Iglesias Peinado I, Bermejo Vicedo T . Prevalence and risk factors for medication reconciliation errors during hospital admission in elderly patients. Int J Clin Pharm. 2016; 38(5):1164-71. DOI: 10.1007/s11096-016-0348-8. View

19.

Sahilu T, Getachew M, Melaku T, Sheleme T . Adverse Drug Events and Contributing Factors Among Hospitalized Adult Patients at Jimma Medical Center, Southwest Ethiopia: A Prospective Observational Study. Curr Ther Res Clin Exp. 2020; 93:100611. PMC: 7689274. DOI: 10.1016/j.curtheres.2020.100611. View

20.

Unroe K, Pfeiffenberger T, Riegelhaupt S, Jastrzembski J, Lokhnygina Y, Colon-Emeric C . Inpatient medication reconciliation at admission and discharge: A retrospective cohort study of age and other risk factors for medication discrepancies. Am J Geriatr Pharmacother. 2010; 8(2):115-26. PMC: 3740385. DOI: 10.1016/j.amjopharm.2010.04.002. View